Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1209
ized, controlled trial of creatine monohydrate in patients with
mitochondrial cytopathies. Muscle Nerve 20: 1502–1509, 1997.
987. TATEMATSU M, OGAWA K, HOSHIYA T, SHICHINO Y, KATO T,
IMAIDA K, AND ITO N. Induction of adenocarcinomas in the
glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea.
Jpn J Cancer Res 83: 915–918, 1992.
988. TATSUMI T, MATOBA S, KOBARA M, KEIRA N, KAWAHARA A,
TSURUYAMA K, TANAKA T, KATAMURA M, NAKAGAWA C,
OHTA B, YAMAHARA Y, ASAYAMA J, AND NAKAGAWA M. Energy
metabolism after ischemic preconditioning in streptozotocininduced
diabetic rat hearts. J Am Coll Cardiol 31: 707–715, 1998.
989. TAYLOR RT, FULTZ E, KNIZE MG, AND FELTON JS. Formation of
the fried ground beef mutagens 2-amino-3-methylimidazo[4,5f]quinoline
(IQ) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP) from L-phenylalanine (Phe) � creatinine (Cre) (or
creatine). Environ Mutagen 9: 106, 1987.
990. TEEL RW, ZHANG Z, HUYNH H, AND HAMILTON S. The effects of
capsaicin on the metabolic activation of heterocyclic amines and
on cytochrome P450 1A2 activity in hamster liver microsomes.
Phytother Res 11: 358–362, 1997.
991. TEICHER BA, MENON K, NORTHEY D, LIU J, KUFE DW, AND
KADDURAH-DAOUK R. Cyclocreatine in cancer chemotherapy.
Cancer Chemother Pharmacol 35: 411–416, 1995.
992. TEN KROODEN E AND OWENS CWI. Creatinine metabolism by
Clostridium welchii isolated from human faeces. Experientia 31:
1270, 1975.
993. TERRILLION KA, KOLKHORST FW, DOLGENER FA, AND
JOSLYN SJ. The effect of creatine supplementation on two 700-m
maximal running bouts. Int J Sports Nutr 7: 138–143, 1997.
994. THIÉBAUD HP, KNIZE MG, KUZMICKY PA, FELTON JS, AND
HSIEH DP. Mutagenicity and chemical analysis of fumes from
cooking meat. J Agric Food Chem 42: 1502–1510, 1994.
995. THOAI NV AND ROBIN Y. Guanidine compounds and phosphagens.
In: Chemical Zoology, edited by M. Florkin and B. T. Scheer.
New York: Academic, 1969, p. 163–203.
996. THOAI NV, ROBIN Y, AND GUILLOU Y. A new phosphagen, N�phosphorylguanidinoethylphospho-O-(�-N,N-dimethyl)serine
(phosphothalassemine). Biochemistry 11: 3890–3895, 1972.
997. THOMAS C, CARR AC, AND WINTERBOURN CC. Free radical
inactivation of rabbit muscle creatine kinase: catalysis by physiological
and hydrolyzed ICRF-187 (ICRF-198) iron chelates. Free
Radical Res 21: 387–397, 1994.
998. THOMAS G AND RAMWELL PW. Identification of guanidino succinate
as a putative endogenous source of the endothelium derived
relaxing factor. Biochem Biophys Res Commun 183: 584–
589, 1992.
999. THOMPSON CH, KEMP GJ, SANDERSON AL, DIXON RM,
STYLES P, TAYLOR DJ, AND RADDA GK. Effect of creatine on
aerobic and anaerobic metabolism in skeletal muscle in swimmers.
Br J Sports Med 30: 222–225, 1996.
1000. THORGEIRSSON UP, GOMEZ DE, LINDSAY CK, SINHA CC, AND
ADAMSON RH. Liver tumors and possible preneoplastic lesions,
induced by a food-derived heterocyclic amine in cynomolgus
monkeys; a study of histology and cytokeratin expression. Liver
16: 71–83, 1996.
1001. THORGEIRSSON UP, SNYDERWINE EG, GOMEZ DE, AND AD-
AMSON RH. Dietary heterocyclic amines as potential human carcinogens:
experimental data from nunhuman primates. In Vivo 10:
145–152, 1996.
1002. THORN GW AND EDER HA. Studies on chronic thyrotoxic myopathy.
Am J Med 1: 583–601, 1946.
1003. THORPE KA, BROCKLEHURST KJ, BLACKBURN SJ, HOLLO-
WAY BR, AND WADDELL ID. Clenbuterol is not an agonist of Na �
dependent creatine transport. Biochem Soc Trans 24: 215S, 1996.
1004. THORUP C AND PERSSON AEG. Macula densa derived nitric
oxide in regulation of glomerular capillary pressure. Kidney Int
49: 430–436, 1996.
1005. TIAN R, CHRISTE ME, SPINDLER M, HOPKINS JCA, HALOW JM,
CAMACHO SA, AND INGWALL JS. Role of MgADP in the development
of diastolic dysfunction in the intact beating rat heart. J Clin
Invest 99: 745–751, 1997.
1006. TIAN R AND INGWALL JS. Energetic basis for reduced contractile
reserve in isolated rat hearts. Am J Physiol Heart Circ Physiol
270: H1207–H1216, 1996.
1007. TIAN R, NASCIMBEN L, INGWALL JS, AND LORELL BH. Failure to
maintain a low ADP concentration impairs diastolic function in
hypertrophied rat hearts. Circulation 96: 1313–1319, 1997.
1008. TIAN R, NASCIMBEN L, KADDURAH-DAOUK R, AND INGWALL
JS. Depletion of energy reserve via the creatine kinase reaction
during the evolution of heart failure in cardiomyopathic hamsters.
J Mol Cell Cardiol 28: 755–765, 1996.
1009. TIKKANEN LM, LATVA-KALA KJ, AND HEINIÖ R-L. Effect of
commercial marinades on the mutagenic activity, sensory quality
and amount of heterocyclic amines in chicken grilled under different
conditions. Food Chem Toxicol 34: 725–730, 1996.
1010. TOLEIKIS AI, KAL’VENAS AA, DZHEYA PP, PRASHKYAVICHYUS
AK, AND YASAITIS AA. Functional changes in the mitochondrial
portion of the adenylate kinase and creatine kinase systems of
energy transport under influence of myocardial ischemia and
adriblastina. Biokhimiya 53: 649–654, 1988.
1011. TOMBES RM AND SHAPIRO BM. Metabolite channeling: a phosphorylcreatine
shuttle to mediate high energy phosphate transport
between sperm mitochondrion and tail. Cell 41: 325–334,
1985.
1012. TORNHEIM K AND LOWENSTEIN JM. Creatine phosphate inhibition
of heart lactate dehydrogenase and muscle pyruvate kinase is
due to a contaminant. J Biol Chem 254: 10586–10587, 1979.
1013. TOYOTA M, USHIJIMA T, KAKIUCHI H, CANZIAN F, WATANABE
M, IMAI K, SUGIMURA T, AND NAGAO M. Genetic alterations in
rat colon tumors induced by heterocyclic amines. Cancer 77:
1593–1597, 1996.
1014. TRACEY I, DUNN JF, AND RADDA GK. Brain metabolism is abnormal
in the mdx model of Duchenne muscular dystrophy. Brain
119: 1039–1044, 1996.
1015. TRAN TC, HUQ TA, KANTES HL, CRANE JN, AND STREIN TG.
Determination of creatinine and other uremic toxins in human
blood sera with micellar electrokinetic capillary electrophoresis.
J Chromatogr 690: 35–42, 1997.
1016. TRICARICO D, CASINI G, AND CONTE CAMERINO D. Effects of
high energy phosphates and L-arginine on the electrical parameters
of ischemic-reperfused rat skeletal muscle fibers. Eur J Pharmacol
287: 17–25, 1995.
1017. TRUMP ME, HEIGENHAUSER GJF, PUTMAN CT, AND SPRIET
LL. Importance of muscle phosphocreatine during intermittent
maximal cycling. J Appl Physiol 80: 1574–1580, 1996.
1018. TSUJI M, ALLRED E, JENSEN F, AND HOLTZMAN D. Phosphocreatine
and ATP regulation in the hypoxic developing rat brain.
Dev Brain Res 85: 192–200, 1995.
1019. TSUKADA K, ABE T, KUWAHATA T, AND MITSUI K. Metabolism
of S-adenosylmethionine in rat hepatocytes: transfer of methyl
group from S-adenosylmethionine by methyltransferase reactions.
Life Sci 37: 665–672, 1985.
1020. TSUNG SH. Creatine kinase activity and isoenzyme pattern in
various normal tissues and neoplasms. Clin Chem 29: 2040–2043,
1983.
1021. TSUNODA S, KAWAMOTO H, INATOMI H, YAMAMOTO K, AND
NAGASAWA H. Inhibition by guanidino compounds of the growth
of spontaneous mammary tumours in SHN mice. Anticancer Res
17: 3349–3354, 1997.
1022. TSURU D, OKA I, AND YOSHIMOTO T. Creatinine decomposing
enzymes in Pseudomonas putida. Agric Biol Chem 40: 1011–1018,
1976.
1023. TU P-H, GURNEY ME, JULIEN J-P, LEE VM-Y, AND TRO-
JANOWSKI JQ. Oxidative stress, mutant SOD1, and neurofilament
pathology in transgenic mouse models of human motor neuron
disease. Lab Invest 76: 441–456, 1997.
1024. TUGANOWSKI W. Electrophysiologic and inotropic effects of
O-benzyl-phosphocreatine in rabbit myocardium. Naunyn-
Schmiedeberg’s Arch Pharmacol 350: 310–314, 1994.
1025. TUGANOWSKI W AND ZIELINSKI W. Inhibitory effects of O-benzyl-phosphocreatine
ethyl ester in rabbit myocardium. J Mol Cell
Cardiol 28: 845–849, 1996.
1026. TULLSON PC, RUSH JWE, WIERINGA B, AND TERJUNG RL.
Alterations in AMP deaminase activity and kinetics in skeletal